Heron Therapeutics | HRTX - Market Capitalization


Heron Therapeutics reported $69M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 5.88B 1.26B Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 35.3B 1.82B Mar/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 12.82B 11.96B Jul/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Pacira USD 915M 149M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 235.82B 34.18B Jul/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Veracyte USD 2.57B 758M Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026